They knew there would be a lot of costs associated with the development of the 5/80 along with building infrastructure to support demand for the new product, and getting FDA approval and getting the bugs worked out on the staple reloading device. It's all done and in place as of yesterday with FDA's stamp on the product. Now we are ready to accelerate even more toward that $.80 price target. Should be there in 2 quarters or less is my opinion.
News 
Market Data 
Discover 
